CP
OGN icon

Castleview Partners’s Organon & Co OGN Stock Holding History

Castleview Partners’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-32
Closed -$602 – 979
2024
Q1 		$602 Buy
+32
New +$549 ﹤0.01% 827
2023
Q2 		– Sell
-1
Closed -$24 – 716
2023
Q1 		$24 Hold
1
– – ﹤0.01% 668
2022
Q4 		$27 Hold
1
– – ﹤0.01% 628
2022
Q3 		$0 Sell
1
-148
-99% -$4.47K ﹤0.01% 712
2022
Q2 		$1.63K Buy
149
+28
+23% +$981 ﹤0.01% 647
2022
Q1 		$4K Buy
+121
New +$4.14K ﹤0.01% 590
2021
Q2 		$4K Buy
+146
New +$4.81K ﹤0.01% 811

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Castleview Partners's OGN Position: Q2 2024 in Review

Castleview Partners sold out of Organon & Co (OGN) in Q2 2024, closing a stake of 32 shares — an estimated $602 sold.

Castleview Partners first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $4K in Q1 2022. 724 funds tracked by Wall St. Rank hold OGN as of Q2 2024.

  • Castleview Partners reported no remaining Organon & Co position as of Q2 2024 after selling out during the quarter.
  • Castleview Partners sold 32 Organon & Co shares in Q2 2024, an estimated $602.
  • Castleview Partners first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • Castleview Partners's Organon & Co position peaked at $4K in Q1 2022.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q2 2024.

Based on Castleview Partners's 13F filing for Q2 2024, filed 31 Jul 2024.